Fumihiko Monma

805 total citations
35 papers, 496 citations indexed

About

Fumihiko Monma is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Fumihiko Monma has authored 35 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 11 papers in Molecular Biology and 9 papers in Genetics. Recurrent topics in Fumihiko Monma's work include Acute Myeloid Leukemia Research (14 papers), Chronic Myeloid Leukemia Treatments (9 papers) and Retinoids in leukemia and cellular processes (8 papers). Fumihiko Monma is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Chronic Myeloid Leukemia Treatments (9 papers) and Retinoids in leukemia and cellular processes (8 papers). Fumihiko Monma collaborates with scholars based in Japan, United States and Poland. Fumihiko Monma's co-authors include Naoyuki Katayama, Hiroshi Shiku, Kohshi Ohishi, Kazuhiro Nishii, Atsushi Fujieda, Masahiro Masuya, Tsutomu Nobori, Yuka Sugimoto, Eiji Usui and Kazunori Nakase and has published in prestigious journals such as Blood, Journal of Clinical Microbiology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Fumihiko Monma

34 papers receiving 492 citations

Peers

Countries citing papers authored by Fumihiko Monma

Since Specialization

Citations

This map shows the geographic impact of Fumihiko Monma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumihiko Monma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumihiko Monma more than expected).

Fields of papers citing papers by Fumihiko Monma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumihiko Monma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumihiko Monma. The network helps show where Fumihiko Monma may publish in the future.

Co-authorship network of co-authors of Fumihiko Monma

This figure shows the co-authorship network connecting the top 25 collaborators of Fumihiko Monma. A scholar is included among the top collaborators of Fumihiko Monma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumihiko Monma. Fumihiko Monma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL 2018 ·Annals of Hematology ·Yoshihiro Hatta, Shuichi Mizuta, Keitaro Matsuo, Shigeki Ohtake, Masako Iwanaga, Isamu Sugiura, Noriko Doki, Heiwa Kanamori, Yasunori Ueda, (unknown), Nobuaki Dobashi, Tomoya Maeda, Toshiaki Yujiri, Fumihiko Monma, Yoshikazu Ito, Fumihiko Hayakawa, Jin Takeuchi, Hitoshi Kiyoi, Yasushi Miyazaki, Tomoki Naoe	29
2	Management of Pulmonary Mucormycosis Based on a Polymerase Chain Reaction (PCR) Diagnosis in Patients with Hematologic Malignancies: A Report of Four Cases 2017 ·Internal Medicine ·(unknown), Kazunori Nakase, Akiko Nakamura, (unknown), Yumiko Sugawara, Kana Miyazaki, Fumihiko Monma, Atsushi Fujieda, Yuka Sugimoto, Kohshi Ohishi, Masahiro Masuya, Naoyuki Katayama	15
3	Effect of Genetic Polymorphism of CYP3A5 and CYP2C19 and Concomitant Use of Voriconazole on Blood Tacrolimus Concentration in Patients Receiving Hematopoietic Stem Cell Transplantation 2015 ·Therapeutic Drug Monitoring ·Takuya Iwamoto, Fumihiko Monma, Atsushi Fujieda, Kaname Nakatani, Alberto Alexander Gayle, Tsutomu Nobori, Naoyuki Katayama, Masahiro Okuda	30
4	A novel FOXP1-PDGFRA fusion gene in myeloproliferative neoplasm with eosinophilia 2015 ·Cancer Genetics ·Yuka Sugimoto, Akiko Sada, (unknown), Fumihiko Monma, Kohshi Ohishi, Masahiro Masuya, Tsutomu Nobori, Toshimitsu Matsui, Naoyuki Katayama	6
5	Long‐term outcome and prognostic factors of elderly patients with acute promyelocytic leukemia 2012 ·Cancer Science ·Takaaki Ono, Akihiro Takeshita, Yuji Kishimoto, Hitoshi Kiyoi, Masaya Okada, Takahiro Yamauchi, Motohiro Tsuzuki, Kentaro Horikawa, Mitsuhiro Matsuda, Katsuji Shinagawa, Fumihiko Monma, Shigeki Ohtake, Chiaki Nakaseko, Masatomo Takahashi, Yukihiko Kimura, Masako Iwanaga, Norio Asou, Tomoki Naoe, (unknown)	18
6	Hepatic Drug Interaction Between Tacrolimus and Lansoprazole in a Bone Marrow Transplant Patient Receiving Voriconazole and Harboring CYP2C19 and CYP3A5 Heterozygous Mutations 2011 ·Clinical Therapeutics ·Takuya Iwamoto, Fumihiko Monma, Atsushi Fujieda, Kaname Nakatani, Naoyuki Katayama, Masahiro Okuda	8
7	Correlation Between Imatinib Pharmacokinetics and Clinical Response in Japanese Patients With Chronic-Phase Chronic Myeloid Leukemia 2010 ·Clinical Pharmacology & Therapeutics ·Naoto Takahashi, Hisashi Wakita, Masatomo Miura, Stuart A. Scott, (unknown), Masayoshi Masuko, Mari Sakai, Yasuhiro Maeda, (unknown), M Kashimura, (unknown), (unknown), Takeo Katayama, Fumihiko Monma, Masahiro Narita, Fumiaki Urase, T Furukawa, Yasushi Miyazaki, Naoyuki Katayama, K Sawada	76
8	Diagnostic Value of PCR Analysis of Bacteria and Fungi from Blood in Empiric-Therapy-Resistant Febrile Neutropenia 2010 ·Journal of Clinical Microbiology ·Akiko Nakamura, Yuka Sugimoto, Kohshi Ohishi, Yumiko Sugawara, Atsushi Fujieda, Fumihiko Monma, Kei Suzuki, Masahiro Masuya, Kazunori Nakase, (unknown), Hideo Wada, Naoyuki Katayama, Tsutomu Nobori	28
9	A potential activity of valproic acid in the stimulation of interleukin-3−mediated megakaryopoiesis and erythropoiesis 2010 ·Experimental Hematology ·Bing Liu, Kohshi Ohishi, (unknown), Kei Suzuki, Fumihiko Monma, (unknown), Masahiro Masuya, (unknown), Yuji Heike, Yoichi Takaue, Naoyuki Katayama	16
10	Second myeloablative allogeneic stem cell transplantation (SCT) using cord blood for leukemia relapsed after initial allogeneic SCT 2008 ·Leukemia Research ·Takaaki Konuma, Jun Ooi, Satoshi Takahashi, Akira Tomonari, Nobuhiro Tsukada, Seiko Kato, Aki Sato, Fumihiko Monma, Senji Kasahara, Kaoru Uchimaru, Tohru Iseki, Arinobu Tojo, Shigetaka Asano	9
11	Unrelated Cord Blood Transplantation after Myeloablative Conditioning in Adults with Acute Myelogenous Leukemia 2008 ·Biology of Blood and Marrow Transplantation ·Jun Ooi, Satoshi Takahashi, Akira Tomonari, Nobuhiro Tsukada, Takaaki Konuma, Seiko Kato, Senji Kasahara, Aki Sato, Fumihiko Monma, Fumitaka Nagamura, Tohru Iseki, Arinobu Tojo, Shigetaka Asano	42
12	Unrelated cord blood transplantation after myeloablative conditioning in adults with ALL 2008 ·Bone Marrow Transplantation ·Jun Ooi, Satoshi Takahashi, Akira Tomonari, N Tsukada, Takaaki Konuma, (unknown), Senji Kasahara, Aki Sato, Fumihiko Monma, Fumitaka Nagamura, (unknown), Arinobu Tojo, S Asano	12
13	Myeloablative unrelated cord blood transplantation for acute leukemia patients between 50 and 55 years of age: single institutional retrospective comparison with patients younger than 50 years of age 2008 ·Annals of Hematology ·Takaaki Konuma, Satoshi Takahashi, Jun Ooi, Akira Tomonari, Nobuhiro Tsukada, Seiko Kato, Aki Sato, Fumihiko Monma, Senji Kasahara, Tokiko Nagamura‐Inoue, Kaoru Uchimaru, Tohru Iseki, Arinobu Tojo, Takuhiro Yamaguchi, Shigetaka Asano	4
14	A case of acute myeloblastic leukemia with a novel variant of t(8;21)(q22;q22) 2007 ·International Journal of Hematology ·Keiki Kawakami, Kazuhiro Nishii, (unknown), Yasuyuki Watanabe, Makoto Nakao, (unknown), Tetsuya Murata, Fumihiko Monma, Shunji Yamamori, (unknown), Ikuo Miura	5
15	Bilateral Osteonecrosis of the Head of the Femur during Treatment with Retinoic Acid in a Young Patient with Acute Promyelocytic Leukemia 2006 ·International Journal of Hematology ·Miho Sakakura, Kazuhiro Nishii, Eiji Usui, Fumihiko Monma, T Tsukada, Hiroshi Shiku	5
16	Molecular and phenotypic analysis of Philadelphia chromosome-positive bilineage leukemia: possibility of a lineage switch from T-lymphoid leukemic progenitor to myeloid cells 2006 ·Cancer Genetics and Cytogenetics ·Fumihiko Monma, Kazuhiro Nishii, (unknown), (unknown), Shunji Yamamori, Eiji Usui, Yuka Sugimoto, Felipe Lorenzo, Naoyuki Katayama, Hiroshi Shiku	19
17	Detection of the CBFB/MYH11 fusion gene in de novo acute myeloid leukemia (AML): A single-institution study of 224 Japanese AML patients 2006 ·Leukemia Research ·Fumihiko Monma, Kazuhiro Nishii, (unknown), (unknown), (unknown), Yasuyuki Watanabe, Keiki Kawakami, (unknown), Shunji Yamamori, Naoyuki Katayama, Hiroshi Shiku	12
18	Granulocytic sarcoma of mesentery in acute myeloid leukemia with CBFB/MYH11 fusion gene but not inv(16) chromosome: Case report and review of literature 2006 ·Leukemia Research ·Atsushi Fujieda, Kazuhiro Nishii, (unknown), Shoichiro Otsuki, Kazuhiko Kobayashi, Fumihiko Monma, Kohshi Ohishi, Kazunori Nakase, Naoyuki Katayama, Hiroshi Shiku	19
19	Molecular analysis of PDGFRα/β genes in core binding factor leukemia with eosinophilia 2005 ·European Journal Of Haematology ·Fumihiko Monma, Kazuhiro Nishii, (unknown), Eiji Usui, (unknown), Yasuyuki Watanabe, Keiki Kawakami, Koji Oka, (unknown), (unknown), Shigehisa Tamaki, Minoru Mizutani, Fumiharu Yagasaki, Noriko Doki, (unknown), Naoyuki Katayama, Hiroshi Shiku	10
20	Upregulated production of IL-6, but not IL-10, by interferon-α induces SOCS3 expression and attenuates STAT1 phosphorylation in myeloma cells 2004 ·The Hematology Journal ·Eiji Usui, Kazuhiro Nishii, Naoyuki Katayama, (unknown), (unknown), Fumihiko Monma, Takemi Otsuki, Hiroshi Shiku	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact